03 nov: Indberetning af ledende medarbejders og disses nærtståendes trans..
06 nov: Sparekassen Sjælland-Fyn A/S : Resultat efter skat stiger meget t..
03-11-2017 17:38:25

Completion of share capital increase

Relateret indhold
Relateret debat
13 jul - 
Njaaah, okay så 😊
13 jul - 
Det er  jo faktisk også det jeg skriver
13 jul - 
hofpeung - jeg forstår din tilgang, men tingene k..

The Board of Directors of BioPorto A/S (BioPorto) decided on October 27, 2017 to partially exercise the authorization in article 16b of the company’s Articles of Association to issue new shares in a private placement to a limited number of shareholders, institutional and financial investors, cf. company announcement no. 13 of October 27, 2017. As announced in company announcement no. 14 of November 2, 2017, the issue was fully subscribed.

Completion of the issue

BioPorto A/S has now received the full subscription amount and the capital increase of in total nominally DKK 13,015,625 has been registered with the Danish Business Authority.

BioPorto A/S’ gross proceeds from the issue amount to DKK 41.7 million. The aggregate net proceeds are expected to amount to DKK 41.0 million after deduction of costs.

Admission to trading and official listing

The new shares will as soon as possible be admitted to trading and official listing on Nasdaq Copenhagen A/S under the ISIN code of the company’s existing shares (ISIN DK0011048619).

Share capital after the rights issue

As a result of the issue, BioPorto A/S’ share capital has been increased by nominally DKK 13,015,625. Accordingly, the total share capital of BioPorto A/S now amounts to DKK 155,509,681 divided into 155,509,681 shares of nominally DKK 1 each, equivalent to 155,509,681 votes. BioPorto A/S’ Articles of Association have been updated accordingly and are available on the company’s website.

For further information please contact:

Peter Mørch Eriksen, CEO

Gry Husby Larsen, Investor relations

Tel.: 45 29 00 00, e-mail investor@bioporto.com

 

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
12 jul
BIOPOR
Så er der under 20 dage (10 børsdage) tilbage til de skal indsende deres FDA bliver spændende og se ..
1

Fondsbørsmeddelelser

#

EuroInvestor: I fokus
#

#

EuroInvestor: I fokus
#

#

EuroInvestor: I fokus
#

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/UBS: Indleder med købsanbefaling og ser aktien stige 37 pct.
2
Novo/ABM: Recepttal understøtter forventning om opjustering
3
Genmab/Jefferies: Darzalex øger tilliden til ledelsens forventninger
4
Aktier/tendens: Genmab og kolleger får udlandsnyt i let nervøs åbning
5
Aktier/åbning: Vestas fører an i positivt C25-indeks

Relaterede aktiekurser

BioPorto A/S 3,150 0,5% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Seneste nyheder


Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. juli 2018 03:03:20
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180712.1 - EUROWEB3 - 2018-07-18 03:03:20 - 2018-07-18 03:03:20 - 1 - Website: OKAY